期刊文献+

紫杉醇脂质体节奏性化疗对胃癌乏氧影响的实验研究 被引量:3

Experimental Study of Effects of Metronomic Chemotherapy with Paclitaxel-Liposomes on Gastric Cancer Hypoxia
下载PDF
导出
摘要 [目的]利用乏氧显像监测紫杉醇脂质体节奏性化疗过程中胃癌的乏氧变化。[方法]36只荷人胃癌HS-746T细胞的雄性裸鼠(4~6周)随机分成两组,治疗组按5mg/kg的剂量每3天一次行腹腔内注射紫杉醇脂质体,对照组注射同体积的生理盐水。治疗后第2d和14d利用SPECT全身静态扫描显示注射99mTc-HL91后5,10,15,30,60,120和180min的显像。在显像上标记感兴趣区为靶点,计算各组靶/非靶比值。然后处死裸鼠、切下肿瘤行称重和放射性计数。通过免疫组织化学染色检测CD34表达,计算肿瘤微血管密度(MVD)。[结果]治疗后第2d,紫杉醇脂质体治疗组T/NT低于对照组(7.82±0.28vs.9.56±0.31,P<0.05),离体肿瘤放射性滞留降低(0.71±0.03vs.0.97±0.03,P<0.05),MVD降低(42.89±2.63vs.52.78±3.09,P<0.05);治疗后第14d,治疗组T/NT高于对照组(11.54±0.42vs.9.96±0.28,P<0.05),离体肿瘤放射性滞留升高(1.42±0.05vs.11.54±0.42,P<0.05),MVD明显降低(27.89±2.51vs.66.11±2.83,P<0.001)。[结论]治疗初期紫杉醇脂质体降低胃癌乏氧,后期乏氧增加,乏氧监测对胃癌的治疗有一定的指导意义。 [Purpose] To monitor the hypoxic change of gastric cancer during metronomic chemotherapy with paclitaxel-liposomes by the hypoxia imaging. [Methods ] Thirty-six male nude mice bearing human gastric cancer HS-746T cells were randomly divided into two groups: The treatment group received paclitaxel-liposomes at a dose of 5mg/kg intraperitoneally and control group received the same volume of saline in every three days. On 2 and 14 days, all the mice underwent static whole body planar imaging with SPECT at 5, 10, 15, 30, 60, 120 and 180 minutes after injection of ^99mTc-HL91. Region of interest, ROI were drawn as the target in planar imagines and target-to-non targeted (T/NT) were calculated. Then the mice were sacrificed and the tumors were removed, weighted and the radioactivities were measured. CD34 expressions were detected by immunohistochemical staining and microvascular densities (MVD) of the tumors were calculated. [Results] On the second days after paclitaxel-liposomes treatment, T/NT ratio of treatment group was significantly lesser than that of control group (7.82±0.28 vs. 9.56±0.31, P〈0.05), the radioactive retention and the MVDs of isolated tumor tissues in the treatment group were lesser than those of control (0.71±0.03 vs. 0.97±0.03,P〈0.05) (42.89± 2.63 vs. 52.78±3.09,P〈0.05). On 14 days after treatment, T/NT ratio and the radioactive retention of treatment group were significantly higher than those of control group (11.54±0.42 vs. 9.96±0.28,P〈 0.05) (1.42±0.05 vs. 11.54±0.42,P〈0.05). The MVD of isolated tumor tissues in the treatment group was significantly lesser than that in control (27.89±2.51 vs. 66.11 ±2.83,P〈0.001 ). [Conclusion]In the early stage of the treatment, paclitaxel-liposomes decrease the hypoxia of gastric cancer and in the late stage of treatment which increases the tumor hypoxia. Therefore, detection tumor hypoxia may be important in guiding the treatment for gastric cancer.
出处 《中国肿瘤》 CAS 2007年第10期809-811,共3页 China Cancer
关键词 ^99MTC-HL91 紫杉醇脂质体 肿瘤乏氧 裸鼠 胃癌细胞 ^99mTc-HL91 paclitaxel-liposomes tumor hypoxia nude mice
  • 相关文献

参考文献7

  • 1郑勇斌 陈道达 许天文 等.泰素帝影响肿瘤乏氧的实验研究.亚洲核医学杂志,2005,5(1):38-41.
  • 2Weidner N.Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors[J].Breast Cancer Res Treat,1995,36(2):169-180.
  • 3Holvoet C,Vander Heyden Y,Lories G,et al.Preparation and evaluation of paclitaxel-containing liposomes[J].Pharmazie,2007,62(2):126-132.
  • 4Ng SS,Sparreboom A,Shaked Y,et al.Influence of formulation vehicle on metronomic taxane chemotherapy:albumin-bound versus cremophor EL-based paclitaxel[J].Clin Cancer Res,2006,12(14 Pt 1):4331-4338.
  • 5Webb T.Vascular normalization:study examines how antiangiogenesis therapies work[J].J Natl Cancer Inst,2005,97(5):336-337.
  • 6Ansiaux R,Baudelet C,Jordan BF,et al.Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment[J].Clin Cancer Res,2005,11 (2 Pt 1):743-750.
  • 7Jain RK.Normalization of tumor vasculature:an emerging concept in antiangiogenic therapy[J].Science,2005,307(5706):58-62.

同被引文献19

  • 1郑勇斌,赫杰,谭海燕,陈道达.转基因联合泰素帝治疗耐药结直肠癌[J].中华实验外科杂志,2006,23(7):798-799. 被引量:1
  • 2秦叔逵,龚新雷.晚期胃癌化疗的现状和新进展[J].临床肿瘤学杂志,2006,11(9):641-652. 被引量:268
  • 3Jain RK,Tong RT,Munn LL.Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension,peritumor edema,and lymphatic metastasis:insights from a mathematical model.Cancer Res,2007,67:2729-2735.
  • 4Jain RK, Tong RT, Munn LL. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumoredema, and lymphatic metastasis: insights from a mathematical model. Cancer Res, 2007,67(6) : 2729-2735.
  • 5Therasse P, Arbuck SG, Eisenhauer EA, et al. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst, 2000,92(3):205-216.
  • 6Kaba H, Fukuda H, Yamamoto S, et al. Reliability at the National Cancer Institute-Common Toxicity Criteria version 2.0. Gan To Kagaku Ryoho, 2004,31(8):1187-1192.
  • 7胃癌临床实践指南(中国版)[EB/OL].2008.http://www.nccn.china.org/images/2008PDF/2008GastrieCancerguidelineChineseedition.pdf.
  • 8Kochi M, Fujii M, Kanamori N, et al. Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer. J Cancer Res Clin Oncol, 2006,132(12) :781-785.
  • 9Horsley MB, Kahook Curr Opin Ophthalmol, Murukesh N, Dive C, and their role in the Cancer, 2010, 102( 1 ) : MY. Anti-VEGF therapy for glaucoma. 2010,21(2) : 112-117.
  • 10Jayson GC. Biomarkers of angiogenesis development of VEGF inhibitors. Br J 8-18.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部